Background: Allergen immunotherapy uses pharmaceutical preparations derived from naturally occurring source materials, which contain water-soluble allergenic components responsible for allergic reactions. The success of in vivo and in vitro diagnoses in allergen sensitization and allergen immunotherapy largely depends on the quality, composition and uniformity of allergenic materials used to produce the active ingredients, and the formulation employed to prepare finished products.Objectives: We aimed to examine the factors influencing batch-to-batch consistency of Jack Jumper (Myrmecia pilosula) ant venom (JJAV) in the form of active pharmaceutical ingredient (AI) and informed whether factors such as temperature, artificial light and cont...
Allergen-specific immunotherapy is the only curative treatment for honeybee venom (HBV) allergy, whi...
Hymenoptera venom allergy is characterised by systemic anaphylactic reactions that occur in response...
Background: A comprehensive diagnostic work-up is essential to ensure adequate patient manageme...
Background: Allergen immunotherapy uses pharmaceutical preparations derived from naturally occurring...
Myrmecia pilosula (Jack Jumper) is an endemic Australian ant whose sting is a frequent cause of inse...
Background: The venomous stings of Jack Jumper ant (JJA; species of the Myrmeciapilosula taxonomic g...
Background: The 'Jack Jumper Ant' (JJA; Myrmecia pilosula species complex) is the major cause of ant...
A major challenge in broader clinical application of Jack Jumper ant venom immunotherapy (JJA VIT) i...
Allergy to Polistes dominula (European paper wasp) venom is of particular relevance in Southern Euro...
In this review, we outline and reflect on the important differences between allergen-specific immuno...
The jack jumper ant, Myrmecia pilosula, is endemic to South-Eastern Australia, where around 2.7% of ...
BACKGROUND: Stings from the Asian needle ant are an important cause of anaphylaxis in East Asia. A 2...
Ants from genus Myrmecia, subfamily Myrmeciinae, are aggressive stinging insects with medical import...
Allergen-specific immunotherapy is the only curative treatment for honeybee venom (HBV) allergy, whi...
Hymenoptera venom allergy is characterised by systemic anaphylactic reactions that occur in response...
Background: A comprehensive diagnostic work-up is essential to ensure adequate patient manageme...
Background: Allergen immunotherapy uses pharmaceutical preparations derived from naturally occurring...
Myrmecia pilosula (Jack Jumper) is an endemic Australian ant whose sting is a frequent cause of inse...
Background: The venomous stings of Jack Jumper ant (JJA; species of the Myrmeciapilosula taxonomic g...
Background: The 'Jack Jumper Ant' (JJA; Myrmecia pilosula species complex) is the major cause of ant...
A major challenge in broader clinical application of Jack Jumper ant venom immunotherapy (JJA VIT) i...
Allergy to Polistes dominula (European paper wasp) venom is of particular relevance in Southern Euro...
In this review, we outline and reflect on the important differences between allergen-specific immuno...
The jack jumper ant, Myrmecia pilosula, is endemic to South-Eastern Australia, where around 2.7% of ...
BACKGROUND: Stings from the Asian needle ant are an important cause of anaphylaxis in East Asia. A 2...
Ants from genus Myrmecia, subfamily Myrmeciinae, are aggressive stinging insects with medical import...
Allergen-specific immunotherapy is the only curative treatment for honeybee venom (HBV) allergy, whi...
Hymenoptera venom allergy is characterised by systemic anaphylactic reactions that occur in response...
Background: A comprehensive diagnostic work-up is essential to ensure adequate patient manageme...